PubMed:2159684
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-30 | protein | denotes | Type II estrogen binding sites |
| T2 | 34-74 | cell_type | denotes | human peripheral blood mononuclear cells |
| T3 | 148-188 | cell_type | denotes | human peripheral blood mononuclear cells |
| T4 | 190-194 | cell_type | denotes | PBMC |
| T5 | 209-234 | protein | denotes | II estrogen binding sites |
| T6 | 236-247 | protein | denotes | type II EBS |
| T7 | 285-296 | protein | denotes | type II EBS |
| T8 | 411-422 | protein | denotes | type II EBS |
| T9 | 546-557 | protein | denotes | type II EBS |
| T10 | 745-756 | protein | denotes | type II EBS |
| T11 | 828-839 | protein | denotes | type II EBS |
| T12 | 843-847 | cell_type | denotes | PBMC |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-114 | Sentence | denotes | Type II estrogen binding sites in human peripheral blood mononuclear cells: variations during the menstrual cycle. |
| S2 | 115-249 | Sentence | denotes | We have previously reported that human peripheral blood mononuclear cells (PBMC) contain type II estrogen binding sites (type II EBS). |
| S3 | 250-371 | Sentence | denotes | In this study, the fluctuations of type II EBS during the menstrual cycle were analyzed in 6 normally menstruating women. |
| S4 | 372-512 | Sentence | denotes | Approximately 3 times higher levels of type II EBS were found in the periovulatory period with respect to both follicular and luteal phases. |
| S5 | 513-633 | Sentence | denotes | In postmenopausal women the mean type II EBS levels were similar to those observed in the follicular phase of the cycle. |
| S6 | 634-764 | Sentence | denotes | However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels. |
| S7 | 765-901 | Sentence | denotes | Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC, although to a lesser extent than diethylstilbestrol. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-30 | NP | denotes | Type II estrogen binding sites |
| C2 | 34-74 | NP | denotes | human peripheral blood mononuclear cells |
| C3 | 94-113 | NP | denotes | the menstrual cycle |
| C4 | 148-195 | NP | denotes | human peripheral blood mononuclear cells (PBMC) |
| C5 | 204-248 | NP | denotes | type II estrogen binding sites (type II EBS) |
| C6 | 285-296 | NP | denotes | type II EBS |
| C7 | 304-323 | NP | denotes | the menstrual cycle |
| C8 | 411-422 | NP | denotes | type II EBS |
| C9 | 537-564 | NP | denotes | the mean type II EBS levels |
| C10 | 581-586 | NP | denotes | those |
| C11 | 623-632 | NP | denotes | the cycle |
| C12 | 702-711 | NP | denotes | tamoxifen |
| C13 | 765-774 | NP | denotes | Tamoxifen |
| C14 | 828-839 | NP | denotes | type II EBS |
| C15 | 843-847 | NP | denotes | PBMC |
| R1 | C4 | C2 | coref-ident | human peripheral blood mononuclear cells (PBMC),human peripheral blood mononuclear cells |
| R2 | C5 | C1 | coref-ident | type II estrogen binding sites (type II EBS),Type II estrogen binding sites |
| R3 | C6 | C5 | coref-ident | type II EBS,type II estrogen binding sites (type II EBS) |
| R4 | C7 | C3 | coref-ident | the menstrual cycle,the menstrual cycle |
| R5 | C8 | C6 | coref-ident | type II EBS,type II EBS |
| R6 | C10 | C9 | coref-pron | those,the mean type II EBS levels |
| R7 | C11 | C7 | coref-ident | the cycle,the menstrual cycle |
| R8 | C13 | C12 | coref-ident | Tamoxifen,tamoxifen |
| R9 | C14 | C8 | coref-ident | type II EBS,type II EBS |
| R10 | C15 | C4 | coref-ident | PBMC,human peripheral blood mononuclear cells (PBMC) |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-30 | protein_family_or_group | denotes | Type II estrogen binding sites |
| T2 | 34-74 | cell_type | denotes | human peripheral blood mononuclear cells |
| T3 | 98-113 | other_name | denotes | menstrual cycle |
| T4 | 148-188 | cell_type | denotes | human peripheral blood mononuclear cells |
| T5 | 190-194 | cell_type | denotes | PBMC |
| T6 | 209-234 | protein_family_or_group | denotes | II estrogen binding sites |
| T7 | 236-247 | protein_family_or_group | denotes | type II EBS |
| T8 | 285-296 | protein_family_or_group | denotes | type II EBS |
| T9 | 308-323 | other_name | denotes | menstrual cycle |
| T10 | 343-370 | multi_cell | denotes | normally menstruating women |
| T11 | 411-422 | protein_family_or_group | denotes | type II EBS |
| T12 | 441-461 | other_name | denotes | periovulatory period |
| T13 | 516-536 | multi_cell | denotes | postmenopausal women |
| T14 | 541-545 | other_name | denotes | mean |
| T15 | 546-557 | protein_family_or_group | denotes | type II EBS |
| T16 | 603-619 | other_name | denotes | follicular phase |
| T17 | 648-671 | multi_cell | denotes | postmenopausal patients |
| T18 | 690-698 | lipid | denotes | estrogen |
| T19 | 702-711 | other_organic_compound | denotes | tamoxifen |
| T20 | 745-756 | protein_family_or_group | denotes | type II EBS |
| T21 | 765-774 | other_organic_compound | denotes | Tamoxifen |
| T22 | 806-823 | lipid | denotes | 17 beta-estradiol |
| T23 | 828-839 | protein_family_or_group | denotes | type II EBS |
| T24 | 843-847 | cell_type | denotes | PBMC |
| T25 | 882-900 | lipid | denotes | diethylstilbestrol |